中潜在的药物标及其在其他神经系统疾病中的作用
Shang Gao1, Yingjie Shen1, Yongze Shen1
1NHC Key Laboratory of Cell Transplantation, Department of Neurosurgery, The First Affiliated Hospital of Harbin Medical University, Heilongjiang Province, Harbin, 150001, People's Republic of China.
Naunyn-Schmiedeberg's archives of pharmacology
|November 18, 2025
概括
TMEM106B被确定为和阿尔茨海默病的潜在药物标. 这种蛋白质在中起着保护作用,但作为阿尔茨海默病和脑内出血的危险因素.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 发病率随神经退行性疾病和中风增加.
- 蛋白质组研究有助于开发治疗干预措施和疾病预防策略.
- TMEM106B与神经系统疾病途径有关.
研究的目的:
- 使用全蛋白质组数据识别的潜在药物标.
- 研究TMEM106B在和其他神经系统疾病中的作用.
- 探索TMEM106B作为和阿尔茨海默病的治疗标.
主要方法:
- 孟德尔随机化 (MR) 分析利用来自血和CSF蛋白质的cis作用蛋白质定量特征位点.
- 同定位分析以确认遗传关联.
- 蛋白质与蛋白质相互作用网络分析.
- 敏感性分析包括反向MR和施泰格过.
主要成果:
- TMEM106B被确定为 (P = 1.29×10−5) 和阿尔茨海默病 (P = 6.11×10−7) 的潜在药物标.
- TMEM106B与脑内出血存在因果关系 (P = 5.00×10−3).
- 血中的TMEM106B对有保护作用,但是阿尔茨海默病和脑内出血的危险因素.
- GRN 和 APOE 蛋白与 TMEM106B 相互作用.
结论:
- TMEM106B是治疗和阿尔茨海默病的有希望的药物标.
- 这项研究强调了TMEM106B在不同神经疾病中的复杂作用.
- 对TMEM106B与GRN和APOE相互作用的进一步研究可能会产生新的治疗策略.
相关概念视频
01:24Epilepsy and Seizures: Overview
1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
01:14Antiepileptic Drugs: Glutamate Antagonists
865
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
865
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
799
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
799
01:17Antiepileptic Drugs: Calcium Channel Blockers
1.1K
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.1K
01:20Antiepileptic Drugs: Potassium Channel Activators
613
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
613